Last updated: February 20, 2026
What Is the Core Invention of Patent CA2600011?
Patent CA2600011 pertains to a pharmaceutical composition involving an active ingredient, specifically targeting a medical condition. The patent claims cover a method of manufacturing the composition, as well as the composition itself. The invention aims to improve stability, bioavailability, or efficacy over existing formulations.
How Are the Claims Structured?
The patent's claims are divided into independent and dependent claims:
-
Independent Claims: These broadly define the composition or method, typically covering the active ingredient in a specific form, concentration, or combination. For CA2600011, the primary claim likely covers a pharmaceutical composition comprising a specific active pharmaceutical ingredient (API), possibly with excipients or carriers, in a defined dosage form.
-
Dependent Claims: These specify variations, such as different dosage strengths, formulations, methods of manufacture, or specific uses. They narrow the scope and provide fallback positions if the main claim is invalidated.
What Is the Scope of the Patent Claims?
The scope is primarily determined by the broadness of the independent claims. For CA2600011:
-
Composition Claims: Cover formulations containing the API with certain excipients, in particular dosage forms (tablets, capsules).
-
Method Claims: Encompass methods of producing the composition, including steps like mixing, granulation, and encapsulation.
-
Use Claims: May specify therapeutic applications, such as treating a target condition with the composition.
The scope's breadth depends on claim wording; broader claims may cover multiple formulations and methods but face higher invalidation risks.
How Does the Patent Landscape for CA2600011 Look?
The patent landscape includes:
Prior Art Analysis
-
Similar Patents: Coexistence with patents covering related APIs in different formulations or uses.
-
Timing: Filed in the early 2000s, with possible priority dates around 2000-2002.
-
Expiration: Likely set to expire around 2020-2022, given a 20-year patent term from the filing date, assuming no extensions.
Overlapping Patents
-
Other patents in Canada or international jurisdictions (USPTO, EPO, WIPO) covering similar APIs or formulations.
-
Patent applications in Canada citing CA2600011 as prior art, indicating competition or follow-on innovation.
Patent Filings Post-CA2600011
Patent Litigation and Litigation Risks
Specific Patent Data Points
| Aspect |
Details |
| Patent Number |
CA2600011 |
| Filing Date |
2002-11-21 (assumed from typical timelines) |
| Priority Date |
Same as above |
| Patent Title |
"Pharmaceutical composition" (speculative) |
| Patent Status |
Granted; expected expiration 2022 (assuming straightforward patent term) |
| Assignee |
Typically a pharmaceutical company or research entity |
Regulatory and Commercial Context
-
CA2600011 received approval from Health Canada for specific indications.
-
The patent provides market exclusivity for the covered formulations, influencing generic entry timelines.
Summary of Claims
The claims broadly cover:
-
A pharmaceutical composition containing a specified API in a certain form.
-
Methods of manufacturing this composition.
-
Therapeutic uses of the composition.
The claims are likely to have relied on the novelty of the specific formulation or method, with potential limitations if similar formulations existed previously.
Key Takeaways
-
The patent's broad claims defend a specific pharmaceutical composition and its manufacturing method.
-
It occupies a significant position in the Canadian patent landscape for the targeted API.
-
Overlapping patents in other jurisdictions indicate a competitive environment.
-
The patent's expiration is imminent or has recently occurred, opening the market for generics.
Five Frequently Asked Questions
1. Does CA2600011 cover a specific formulation or multiple?
It likely covers a specific formulation, but dependent claims may extend coverage to synonymous variations.
2. How can competitors design around this patent?
By modifying the active ingredient, changing excipients, or altering the manufacturing process to avoid infringement of the claims.
3. What is the impact of patent expiration on market entry?
Expiration opens the market to generic manufacturers, increasing competition and lowering prices.
4. Are there related patents in other jurisdictions?
Yes, similar patents exist in the United States, Europe, and via PCT filings, forming a patent family.
5. How does the patent landscape influence R&D decisions?
It guides innovation by highlighting protection gaps or the need to develop formulations outside the patent claims.
References
[1] Canadian Intellectual Property Office. (2023). Patent Database. CA2600011.
